Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

65.62
-0.2900-0.44%
Pre-market: 59.74-5.8823-8.96%04:00 EDT
Volume:1.72M
Turnover:113.77M
Market Cap:9.12B
PE:-9.14
High:67.27
Open:65.73
Low:65.30
Close:65.91
52wk High:88.31
52wk Low:54.30
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.76
T/O Rate:1.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-52.58
PE(LYR):-10.03

Loading ...

Cytokinetics price target raised to $103 from $90 at Morgan Stanley

TIPRANKS
·
May 07

BRIEF-Cytokinetics Prices Public Offering Of 9.8 Mln Shares At $71/Share

Reuters
·
May 07

Cytokinetics prices upsized follow-on offering of 9,859,155 shares at $71 each

Reuters
·
May 07

Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock

THOMSON REUTERS
·
May 07

Cytokinetics Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
May 07

Cytokinetics' Rapid Growth of Myqorzo not Fully Priced in by Investors, RBC Says

MT Newswires Live
·
May 07

BUZZ-Cytokinetics slides on stock sale plans following heart disease study

Reuters
·
May 07

RBC Adds Speculative Risk to Outperform Rating on Cytokinetics, Lifts Price Target to $119 From $101

MT Newswires Live
·
May 06

Cytokinetics Inc : RBC Raises Target Price to $119 From $101

THOMSON REUTERS
·
May 06

Cytokinetics Inc : Needham Raises Target Price to $102 From $85

THOMSON REUTERS
·
May 06

Cytokinetics Earnings Call Highlights Launch, Trial Wins

TIPRANKS
·
May 06

Cytokinetics EVP R&D Malik Fady Ibraham disposes 3,500 shares worth $270,795

Reuters
·
May 06

Cytokinetics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 06

BRIEF-Cytokinetics Inc - Offers Common Stock With Aggregate Public Offering Price Of $650 Million - SEC Filing

Reuters
·
May 06

Cytokinetics Inc - Offers Common Stock With Aggregate Public Offering Price of $650 Mln - SEC Filing

THOMSON REUTERS
·
May 06

Cytokinetics plans $650 million common stock offering

Reuters
·
May 06

Earnings Flash (CYTK) Cytokinetics Posts Q1 Loss $1.67, vs. FactSet Est of $1.65 Loss

MT Newswires Live
·
May 06

Cytokinetics Highlights MYQORZO Progress and Cardiology Pipeline

TIPRANKS
·
May 06

Cytokinetics Q1 revenue jumps on MYQORZO launch

Reuters
·
May 06

Cytokinetics director Wendell Wierenga sells 4,032 shares for $302,400

Reuters
·
May 06